# Enhanced Recovery Pathway for Endoscopy

> **NCT04983498** · PHASE4 · WITHDRAWN · sponsor: **Northwestern University**

## Conditions studied

- Enhanced Recovery Pathway
- Endoscopy

## Interventions

- **DRUG:** Ondansetron 4 MG
- **DRUG:** Lactated Ringers, Intravenous
- **OTHER:** Early Mobilization
- **OTHER:** Early PO Intake

## Key facts

- **NCT ID:** NCT04983498
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-09-01
- **Primary completion:** 2021-12-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Investigator left organization before study initiated.
- **Last updated:** 2021-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04983498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04983498, "Enhanced Recovery Pathway for Endoscopy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04983498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*